![(−)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin, HCl - chemical structure image](https://media.scbt.com/product/minus-3-4-4a-5-6-10b-hexahydro-9-methoxy-2h-naphtho1-2-b1-4oxazin-hcl-structure_13_40_b_134032.jpg)
![(−)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin, HCl - chemical structure image](https://media.scbt.com/product/minus-3-4-4a-5-6-10b-hexahydro-9-methoxy-2h-naphtho1-2-b1-4oxazin-hcl-structure_13_40_t_134032.jpg "(-)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin, HCl 의 분자 구조")
(-)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin, HCl 의 분자 구조
(-)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin, HCl
적용:
(−)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin, HCl is a dopamine antagonist and dopaminergic ligand
분자량:
255.74
분자식:
C13H18ClNO2
연구용으로만 사용가능합니다. 진단이나 치료용으로 사용불가합니다.
* Refer to Certificate of Analysis for lot specific data.
빠른 링크
주문정보
설명
기술정보
안전정보
SDS 및 분석 증명서
(-)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin, HCl 참고자료
Dijkstra, D., et al.: J. Med. Chem., 45, 3022 (2002)주문정보
| 제품명 | 카탈로그 번호 | 단위 | 가격 | 수량 | 관심품목 | |
(-)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin, HCl, 5 mg | sc-216589 | 5 mg | $330.00 |